NEWS

WIRES

OTHER

Cegedim Dendrite Survey Uncovers 35% of Pharmaceutical Executives Concerned over Changing Commercial Business Models

The survey found 35 percent of respondents saw changing commercial business models as the most pressing issue. The biggest changes to business models currently being implemented are an increased focus on market access strategies (40%), primary sales force re-alignment (20%) and a greater focus on managed care (17%).

Cegedim Dendrite's 2010 Pharmaceutical Insights Survey report covers current topics such as identifying key corporate objectives, drivers of business model changes and anticipated changes to current business models, among a myriad of interesting topics.

According to the survey, top objectives for 2010 include new product innovation and launch (67%) and profitability growth (51%). Also, government and regulatory reform, as well as generic competition, are cited as areas of both current and future concern.

"It came as no surprise to learn that the greatest concern is the changing commercial business model," stated Angela Miccoli, President of Cegedim Dendrite Americas. "Life Sciences companies need a way to respond to a rapidly evolving industry that is presented with market access challenges, extreme competitive pressures and stiffer regulatory requirements." According to Miccoli, "Our vast local footprint in over sixty countries, deep understanding of the Life Sciences industry and proven solutions in CRM, regulatory compliance, data and marketing solutions enables us to deliver integrated solutions for pharmaceutical sales, marketing and IT professionals to overcome these challenges."

For a full report on the survey results, please visit www.cegedimdendrite.com/pharma-insights.

Other industry survey reports published by Cegedim Dendrite include:

• Trends in Aggregate Spend and Disclosure Reporting Compliance (Feb 2010)
  www.cegedimdendrite.com/agg-spend-2010
• The Cegedim Dendrite Market Access Industry Report (June 2010)
  www.cegedimdendrite.com/market-access-2010
• 2010 Direct-To-Consumer Industry Check-Up (June 2010)
  www.cegedimdendrite.com\dtc2010

About Cegedim Dendrite

Cegedim Dendrite is the Life Sciences industry's leading provider of Customer Relationship Management (CRM) solutions. Designed specifically for Life Sciences, the company's innovative business solutions incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Dendrite enables more than 200,000 users in many of the world's most innovative companies to stay ahead of market challenges. In addition to CRM, Cegedim Dendrite also provides marketing, data optimization and regulatory compliance solutions in more than 80 countries.

Cegedim Dendrite is part of the France-based Cegedim S.A. Group.

To learn more, please visit www.cegedimdendrite.com.

About Cegedim

Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,600 people in more than 80 countries and generated revenue of €874 million in 2009.

Cegedim SA is listed in Paris (EURONEXT: CGM).

To learn more, please visit: www.cegedim.com

Cegedim Dendrite
Global Communications
Drew Bustos, +1 (908) 443.2451
drew.bustos@cegedimdendrite.com
or
Cegedim Group
Media Relations
Aude Balleydier, + 33 (0)1 49 09 68 81
aude.balleydier@cegedim.fr